Cargando…

Aminoglycoside-Modifying Enzymes Are Sufficient to Make Pseudomonas aeruginosa Clinically Resistant to Key Antibiotics

Aminoglycosides are widely used to treat infections of Pseudomonas aeruginosa. Genes encoding aminoglycoside-modifying enzymes (AMEs), acquired by horizontal gene transfer, are commonly associated with aminoglycoside resistance, but their effects have not been quantified. The aim of this research wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thacharodi, Aswin, Lamont, Iain L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312099/ https://www.ncbi.nlm.nih.gov/pubmed/35884138 http://dx.doi.org/10.3390/antibiotics11070884

Ejemplares similares

Gene–Gene Interactions Reduce Aminoglycoside Susceptibility of Pseudomonas aeruginosa through Efflux Pump-Dependent and -Independent Mechanisms
por: Thacharodi, Aswin, et al.
Publicado: (2023)

Role of Aminoglycoside-Modifying Enzymes (AMEs) in Resistance to Aminoglycosides among Clinical Isolates of Pseudomonas aeruginosa in the North of Iran
por: Ahmadian, Leila, et al.
Publicado: (2021)

TpiA is a Key Metabolic Enzyme That Affects Virulence and Resistance to Aminoglycoside Antibiotics through CrcZ in Pseudomonas aeruginosa
por: Xia, Yushan, et al.
Publicado: (2020)

Evaluation on the Use of β-Lactamase and Aminoglycoside Modifying Enzyme Gene Sequences as Markers for the Early Detection of Antibiotic Resistance Profile of Pseudomonas aeruginosa
por: Doss, Victor A., et al.
Publicado: (2004)

Expression of the MexXY Aminoglycoside Efflux Pump and Presence of an Aminoglycoside-Modifying Enzyme in Clinical Pseudomonas aeruginosa Isolates Are Highly Correlated
por: Seupt, Alexander, et al.
Publicado: (2020)

In vivo Host Environment Alters Pseudomonas aeruginosa Susceptibility to Aminoglycoside Antibiotics
por: Pan, Xiaolei, et al.
Publicado: (2017)

4F-Indole Enhances the Susceptibility of Pseudomonas aeruginosa to Aminoglycoside Antibiotics
por: Dou, Qin, et al.
Publicado: (2023)

Artemisinin derivative DHA27 enhances the antibacterial effect of aminoglycosides against Pseudomonas aeruginosa by inhibiting mRNA expression of aminoglycoside-modifying enzymes
por: Wang, Nuoyan, et al.
Publicado: (2022)

Structure of Pseudomonas aeruginosa ribosomes from an aminoglycoside-resistant clinical isolate
por: Halfon, Yehuda, et al.
Publicado: (2019)

AMINOGLYCOSIDE RESISTANCE GENES IN Pseudomonas aeruginosa ISOLATES FROM CUMANA, VENEZUELA
por: TEIXEIRA, Bertinellys, et al.
Publicado: (2016)

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2018)

Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas Aeruginosa
por: Kosai, Kosuke, et al.
Publicado: (2017)

MexY-Promoted Aminoglycoside Resistance in Pseudomonas aeruginosa: Involvement of a Putative Proximal Binding Pocket in Aminoglycoside Recognition
por: Lau, Calvin Ho-Fung, et al.
Publicado: (2014)

Modification at the 2′-Position of the 4,5-Series of 2-Deoxystreptamine Aminoglycoside Antibiotics To Resist Aminoglycoside Modifying Enzymes and Increase Ribosomal Target Selectivity
por: Sati, Girish C., et al.
Publicado: (2019)

β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects
por: Glen, Karl A., et al.
Publicado: (2021)

Analysis of Aminoglycoside Modifying Enzyme Genes Responsible for High-Level Aminoglycoside Resistance among Enterococcal Isolates
por: Shete, Vishal, et al.
Publicado: (2017)

Genome-Scale Identification Method Applied to Find Cryptic Aminoglycoside Resistance Genes in Pseudomonas aeruginosa
por: Struble, Julie M., et al.
Publicado: (2009)

Triclosan depletes the membrane potential in Pseudomonas aeruginosa biofilms inhibiting aminoglycoside induced adaptive resistance
por: Maiden, Michael M., et al.
Publicado: (2020)

Genomics of Aminoglycoside Resistance in Pseudomonas aeruginosa Bloodstream Infections at a United States Academic Hospital
por: Atassi, Giancarlo, et al.
Publicado: (2023)

The prevalence of aminoglycoside-modifying enzyme genes (aac (6′)-I, aac (6′)-II, ant (2″)-I, aph (3′)-VI) in Pseudomonas aeruginosa
por: Vaziri, Farzam, et al.
Publicado: (2011)

Ceftazidime resistance in Pseudomonas aeruginosa is multigenic and complex
por: Ramsay, Kay A., et al.
Publicado: (2023)

The Effects of Sub-inhibitory Antibiotic Concentrations on Pseudomonas aeruginosa: Reduced Susceptibility Due to Mutations
por: Ramsay, Kay A., et al.
Publicado: (2021)

Correlation of Aminoglycoside Consumption and Amikacin- or Gentamicin-Resistant Pseudomonas aeruginosa in Long-Term Nationwide Analysis: Is Antibiotic Cycling an Effective Policy for Reducing Antimicrobial Resistance?
por: Kim, Young Ah, et al.
Publicado: (2018)

Pseudomonas aeruginosa is oxygen-deprived during infection in cystic fibrosis lungs, reducing the effectiveness of antibiotics
por: Martin, Lois W, et al.
Publicado: (2023)

Prevalence of resistance to aminoglycosides and fluoroquinolones among Pseudomonas aeruginosa strains in a University Hospital in Northeastern Poland
por: Michalska, Anna Diana, et al.
Publicado: (2015)

The prevalence of aminoglycoside-modifying enzyme and virulence genes among enterococci with high-level aminoglycoside resistance in Inner Mongolia, China
por: Niu, Haiying, et al.
Publicado: (2016)

Prevalence of Aminoglycoside Resistance and Aminoglycoside Modifying Enzymes in Acinetobacter baumannii Among Intensive Care Unit Patients, Ismailia, Egypt
por: Kishk, Rania, et al.
Publicado: (2021)

Genomics of antibiotic‐resistance prediction in Pseudomonas aeruginosa
por: Jeukens, Julie, et al.
Publicado: (2017)

Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms
por: Fernández-Billón, María, et al.
Publicado: (2023)

Ecology, more than antibiotics consumption, is the major predictor for the global distribution of aminoglycoside-modifying enzymes
por: Pradier, Léa, et al.
Publicado: (2023)

Prevalence of Aminoglycoside Resistance Genes in Clinical Isolates of Pseudomonas aeruginosa from Taif, Saudi Arabia—An Emergence Indicative Study
por: El-Far, Shaymaa W., et al.
Publicado: (2023)

Role of aminoglycoside-modifying enzymes and 16S rRNA methylase (ArmA) in resistance of Acinetobacter baumannii clinical isolates against aminoglycosides
por: Jouybari, Maryam Asadi, et al.
Publicado: (2021)

Mutation to ispA Produces Stable Small-Colony Variants of Pseudomonas aeruginosa That Have Enhanced Aminoglycoside Resistance
por: Pitton, Melissa, et al.
Publicado: (2022)

Biophysical and enzymatic properties of aminoglycoside adenylyltransferase AadA6 from Pseudomonas aeruginosa
por: Papadovasilaki, Maria, et al.
Publicado: (2015)

Effect of cardiolipin on the antimicrobial activity of a new amphiphilic aminoglycoside derivative on Pseudomonas aeruginosa
por: Swain, Jitendriya, et al.
Publicado: (2018)

2274. Comparison of Clinical Outcomes in Patients with Extensively Drug-Resistant Pseudomonas aeruginosa Pneumonia Treated with Aminoglycosides vs. Ceftolozane/Tazobactam
por: Pervin, Najwa, et al.
Publicado: (2019)

The dilemma of antibiotic susceptibility and clinical decision-making in a multi-drug-resistant Pseudomonas aeruginosa bloodstream infection
por: Chen, Long, et al.
Publicado: (2023)

Evolution of Habitat-Dependent Antibiotic Resistance in Pseudomonas aeruginosa
por: Laborda, Pablo, et al.
Publicado: (2022)

An usual approach to treatment of a case of multidrug resistance Pseudomonas aeruginosa peritonitis: parenteral and intraperitoneal aminoglycosides and parenteral colistin
por: May, Ian, et al.
Publicado: (2012)

Berberine Is a Novel Type Efflux Inhibitor Which Attenuates the MexXY-Mediated Aminoglycoside Resistance in Pseudomonas aeruginosa
por: Morita, Yuji, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u3d8715l508cegjm92rrje4d8j